Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
About this item
Full title
Author / Creator
Publisher
England: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were tr...
Alternative Titles
Full title
Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1771447932
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1771447932
Other Identifiers
ISSN
0916-9636
E-ISSN
1348-4214
DOI
10.1038/hr.2015.129
